Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-24-024463
Filing Date
2024-10-02
Accepted
2024-10-02 17:15:05
Documents
1
Period of Report
2024-10-01

Document Format Files

Seq Description Document Type Size
1 form4-10022024_051001.html 4  
1 form4-10022024_051001.xml 4 4058
  Complete submission text file 0001415889-24-024463.txt   5462
Mailing Address 828 WINTER STREET WALTHAM MA 02451
Business Address 828 WINTER STREET WALTHAM MA 02451 617-833-1027
Xilio Therapeutics, Inc. (Issuer) CIK: 0001840233 (see all company filings)

EIN.: 851623397 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O XILIO THERAPEUTICS, INC. 828 WINTER STREET WALTHAM MA 02451
Business Address
Brennan Kevin M. (Reporting) CIK: 0001971303 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40925 | Film No.: 241348757